|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
157,644,000 |
Market
Cap: |
N/A |
Last
Volume: |
3,641,286 |
Avg
Vol: |
1,652,431 |
52
Week Range: |
$0.034 - $0.034 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Schiffman Greogry T |
CFO, SVP of Finance & Treasure |
|
2011-10-15 |
4 |
D |
$9.75 |
$18,876 |
D/D |
(1,936) |
212,699 |
|
- |
|
Monteith William |
EVP Technical Operations |
|
2011-09-30 |
4 |
D |
$7.87 |
$1,149 |
D/D |
(146) |
19,818 |
|
- |
|
Bayh Susan B |
Director |
|
2011-09-09 |
4 |
B |
$11.05 |
$220,958 |
D/D |
20,000 |
40,757 |
2.39 |
- |
|
Osborn John E |
EVP, General Counsel |
|
2011-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
37,000 |
37,000 |
|
- |
|
Johnson John H |
Director |
|
2011-08-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,443 |
10,443 |
|
- |
|
Urdal David |
SVP, Chief Scientific Officer |
|
2011-08-09 |
4 |
OE |
$4.41 |
$57,364 |
D/D |
12,035 |
588,115 |
|
- |
|
Frohlich Mark W |
See General Remarks |
|
2011-08-04 |
4 |
OE |
$4.90 |
$66,503 |
D/D |
11,362 |
191,024 |
|
- |
|
Ranieri Richard J |
SVP, Human Resources |
|
2011-07-31 |
4 |
D |
$36.90 |
$29,372 |
D/D |
(796) |
56,492 |
|
- |
|
Bishop Hans Edgar |
Chief Operating Officer |
|
2011-07-29 |
4 |
D |
$37.65 |
$86,256 |
D/D |
(2,291) |
151,189 |
|
- |
|
Gold Mitchell |
President & Chief Executive Of |
|
2011-07-25 |
4 |
OE |
$4.90 |
$19,017 |
D/D |
3,881 |
229,666 |
|
- |
|
Gold Mitchell |
President & Chief Executive Of |
|
2011-07-25 |
4 |
AS |
$38.37 |
$728,964 |
D/D |
(19,000) |
225,785 |
|
- |
|
Monteith William |
EVP Technical Operations |
|
2011-07-21 |
4 |
D |
$39.02 |
$5,229 |
D/D |
(134) |
19,964 |
|
- |
|
Cox Greg |
VP, Finance |
|
2011-07-21 |
4 |
D |
$39.02 |
$4,917 |
D/D |
(126) |
22,627 |
|
- |
|
Frohlich Mark W |
See General Remarks |
|
2011-07-21 |
4 |
AS |
$39.13 |
$126,402 |
D/D |
(3,230) |
179,662 |
|
- |
|
Schiffman Greogry T |
CFO, SVP of Finance & Treasure |
|
2011-07-21 |
4 |
D |
$39.13 |
$16,709 |
D/D |
(427) |
214,635 |
|
- |
|
Gold Mitchell |
President & Chief Executive Of |
|
2011-07-21 |
4 |
D |
$39.13 |
$50,126 |
D/D |
(1,281) |
244,785 |
|
- |
|
Urdal David |
SVP, Chief Scientific Officer |
|
2011-07-21 |
4 |
AS |
$38.75 |
$39,331 |
D/D |
(1,015) |
576,080 |
|
- |
|
Cox Greg |
VP, Finance |
|
2011-07-17 |
4 |
D |
$38.45 |
$3,653 |
D/D |
(95) |
22,753 |
|
- |
|
Urdal David |
SVP, Chief Scientific Officer |
|
2011-07-17 |
4 |
AS |
$38.43 |
$78,205 |
D/D |
(2,035) |
577,095 |
|
- |
|
Gold Mitchell |
President & Chief Executive Of |
|
2011-07-17 |
4 |
D |
$38.80 |
$82,334 |
D/D |
(2,122) |
246,066 |
|
- |
|
Schiffman Greogry T |
CFO, SVP of Finance & Treasure |
|
2011-07-17 |
4 |
D |
$38.80 |
$28,751 |
D/D |
(741) |
215,062 |
|
- |
|
Cox Greg |
VP, Finance |
|
2011-07-15 |
4 |
D |
$38.43 |
$9,761 |
D/D |
(254) |
22,848 |
|
- |
|
Urdal David |
SVP, Chief Scientific Officer |
|
2011-07-15 |
4 |
AS |
$39.19 |
$208,177 |
D/D |
(5,312) |
579,130 |
|
- |
|
Gold Mitchell |
President & Chief Executive Of |
|
2011-07-15 |
4 |
D |
$38.80 |
$154,657 |
D/D |
(3,986) |
248,188 |
|
- |
|
Schiffman Greogry T |
CFO, SVP of Finance & Treasure |
|
2011-07-15 |
4 |
D |
$38.80 |
$75,117 |
D/D |
(1,936) |
215,803 |
|
- |
|
721 Records found
|
|
Page 13 of 29 |
|
|